What are the key differences between the R21 Oxford vaccine and the earlier GSK malaria vaccine RTSS?
Answered at 19:40 in Parasite, the Malaria (Tech & Science) Edition · 16 Minutes News by a16z
What are the key differences between the R21 Oxford vaccine and the earlier GSK malaria vaccine RTSS?
Both the R21 and GSK's RTSS use similar adjuvants derived from tree bark and employ the same virus-like particle approach using hepatitis B surface antigen as the core particle. The primary difference is that R21 contains less hepatitis B surface antigen protein and proportionally much more malaria protein on the particle than RTSS, which is thought to be a potential contributor to R21's higher efficacy of 77 percent versus GSK's initial 56 percent efficacy.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
Both the R21 and GSK's RTSS use similar adjuvants derived from tree bark and employ the same virus-like particle approach using hepatitis B surface antigen as the core particle.
Rajiv Venkayya · Parasite, the Malaria (Tech & Science) Edition · 16 Minutes News by a16z · answer at 19:40
Key takeaways
- Both the R21 and GSK's RTSS use similar adjuvants derived from tree bark and employ the same virus-like particle approach using hepatitis B surface antigen as the core particle.
The full answer · about 6 min
Both the R21 and GSK's RTSS use similar adjuvants derived from tree bark and employ the same virus-like particle approach using hepatitis B surface antigen as the core particle. The primary difference is that R21 contains less hepatitis B surface antigen protein and proportionally much more malaria protein on the particle than RTSS, which is thought to be a potential contributor to R21's higher efficacy of 77 percent versus GSK's initial 56 percent efficacy.
More answers from this episode
- 4:30Why is malaria considered one of the most difficult diseases to develop a vaccine against?
- 7:00What is the mechanism by which the R21 malaria vaccine achieves its protective effect through virus-like particles?
- 15:30What is the distinction between preventing illness versus blocking transmission in malaria vaccine design?
- 17:27How does the adjuvant Matrix M enhance the effectiveness of the R21 vaccine in clinical trials?
- 18:45Why was a rabies vaccine used as the control group rather than saline in the R21 phase 2B trial?